Cargando…
Development of a Positive-readout Mouse Model of siRNA Pharmacodynamics
Development of RNAi-based therapeutics has the potential to revolutionize treatment options for a range of human diseases. However, as with gene therapy, a major barrier to progress is the lack of methods to achieve and measure efficient delivery for systemic administration. We have developed a posi...
Autores principales: | Stevenson, Mark, Carlisle, Robert, Davies, Ben, Preece, Chris, Hammett, Michelle, Liu, Wei-li, Fisher, Kerry David, Ryan, Amy, Scrable, Heidi, Seymour, Leonard William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889190/ https://www.ncbi.nlm.nih.gov/pubmed/24253258 http://dx.doi.org/10.1038/mtna.2013.63 |
Ejemplares similares
-
Establishment of a positive-readout reporter system for siRNAs
por: Liu, Wei-li, et al.
Publicado: (2009) -
Quantification of siRNA using competitive qPCR
por: Liu, Wei-li, et al.
Publicado: (2009) -
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
por: Brown, Christopher R, et al.
Publicado: (2020) -
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
por: Nair, Jayaprakash K., et al.
Publicado: (2017) -
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
por: Mui, Barbara L, et al.
Publicado: (2013)